• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于灌注的冷冻卵巢癌组织体外培养,保留肿瘤微环境。

Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment.

作者信息

De Luise Monica, Kurelac Ivana, Coluccelli Sara, De Leo Antonio, Bartoszek Ewelina M, Iorio Maria, Grillini Marco, Coadă Camelia Alexandra, de Biase Dario, Marchio Lorena, López Mónica Núñez, Rimmer Natalie, Perrone Anna Myriam, De Iaco Pierandrea, Porcelli Anna Maria, Heinzelmann Viola, Martin Ivan, Jacob Francis, Muraro Manuele Giuseppe, Gasparre Giuseppe

机构信息

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.

Centre for Applied Biomedical Research, University of Bologna, Bologna, Italy.

出版信息

NPJ Precis Oncol. 2025 May 23;9(1):152. doi: 10.1038/s41698-025-00941-6.

DOI:10.1038/s41698-025-00941-6
PMID:40410344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12102267/
Abstract

Ovarian cancer (OC) poses significant treatment challenges due to late-stage diagnosis and a complex tumor microenvironment contributing to therapy resistance. We optimized a U-CUP perfusion-based bioreactor method to culture patient-derived primary and metastatic OC specimens, demonstrating that perfusion better preserves cancer cell viability and proliferation, both when fresh and slow-frozen tissues were used. Perfused cultures maintained key microenvironment components, including cancer-associated fibroblasts, endothelial and immune cells. Genetic analysis confirmed the retention in culture of tumor-specific driver mutations. We hence challenged ad hoc generated cisplatin-sensitive and resistant OC cells with cisplatin during growth in U-CUP, validating our system for the testing of drug response. Finally, treatment of slow-frozen OC tissues with carboplatin/paclitaxel revealed different degrees of response to treatment, as indicated by variations in tumor necrosis and number of residual PAX8 cells, providing the bases for the prompt evaluation of OC standard chemotherapy efficacy in our ex vivo system.

摘要

卵巢癌(OC)由于诊断时已处于晚期以及复杂的肿瘤微环境导致治疗耐药性,给治疗带来了重大挑战。我们优化了一种基于U-CUP灌注的生物反应器方法,用于培养患者来源的原发性和转移性OC标本,结果表明,无论是使用新鲜组织还是慢速冷冻组织,灌注都能更好地保持癌细胞的活力和增殖。灌注培养物保留了关键的微环境成分,包括癌症相关成纤维细胞、内皮细胞和免疫细胞。基因分析证实了肿瘤特异性驱动突变在培养中的保留。因此,我们在U-CUP中培养时,用顺铂对临时生成的顺铂敏感和耐药OC细胞进行了挑战,验证了我们用于测试药物反应的系统。最后,用卡铂/紫杉醇治疗慢速冷冻的OC组织,结果显示出不同程度的治疗反应,这通过肿瘤坏死和残余PAX8细胞数量的变化得以体现,为在我们的体外系统中快速评估OC标准化疗疗效提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/ae6f625613fd/41698_2025_941_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/1269a06a5b1a/41698_2025_941_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/38e7fe3b4764/41698_2025_941_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/5652bd6ba083/41698_2025_941_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/018d09b91edf/41698_2025_941_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/ae6f625613fd/41698_2025_941_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/1269a06a5b1a/41698_2025_941_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/38e7fe3b4764/41698_2025_941_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/5652bd6ba083/41698_2025_941_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/018d09b91edf/41698_2025_941_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7077/12102267/ae6f625613fd/41698_2025_941_Fig5_HTML.jpg

相似文献

1
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment.基于灌注的冷冻卵巢癌组织体外培养,保留肿瘤微环境。
NPJ Precis Oncol. 2025 May 23;9(1):152. doi: 10.1038/s41698-025-00941-6.
2
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer.专家共识:晚期或转移性上皮性卵巢癌的评估和管理。
Rev Colomb Obstet Ginecol. 2024 Jun 14;75(1):4094. doi: 10.18597/rcog.4094.
3
Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion.黄酮类化合物以磷酸化 ERK1/2 依赖的方式恢复卵巢癌细胞对铂类药物的敏感性。
Int J Mol Sci. 2020 Sep 7;21(18):6533. doi: 10.3390/ijms21186533.
4
PCL-PEtOx-based Crystalline-core Micelles for the Targeted Delivery of Paclitaxel and Trabectedin in Ovarian Cancer Therapy.基于聚己内酯-聚乙交酯的结晶核胶束用于卵巢癌治疗中紫杉醇和曲贝替定的靶向递送
Acta Biomater. 2025 Apr 28. doi: 10.1016/j.actbio.2025.04.050.
5
Systematic profiling of cancer-fibroblast interactions reveals drug combinations in ovarian cancer.对癌症-成纤维细胞相互作用的系统分析揭示了卵巢癌中的联合用药方案。
Mol Oncol. 2025 May 24. doi: 10.1002/1878-0261.70051.
6
Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway.尼拉帕利联合顺铂和 Twist 敲低在顺铂耐药卵巢癌细胞中通过内质网应激介导的线粒体凋亡途径增强合成致死作用。
Int J Mol Sci. 2021 Apr 10;22(8):3916. doi: 10.3390/ijms22083916.
7
Using genetically encoded fluorescent biosensors to interrogate ovarian cancer metabolism.利用基因编码荧光生物传感器检测卵巢癌代谢。
J Ovarian Res. 2022 Oct 20;15(1):114. doi: 10.1186/s13048-022-01046-5.
8
Maintenance of Primary Human Colorectal Cancer Microenvironment Using a Perfusion Bioreactor-Based 3D Culture System.使用基于灌注生物反应器的3D培养系统维持原发性人类结直肠癌微环境
Adv Biosyst. 2019 Apr;3(4):e1800300. doi: 10.1002/adbi.201800300. Epub 2019 Mar 7.
9
Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis.利用整合生物信息学分析鉴定 EMP1 为卵巢癌顺铂耐药的关键基因。
Cancer Med. 2023 Apr;12(7):9024-9040. doi: 10.1002/cam4.5637. Epub 2023 Jan 27.
10
Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids.卵巢癌球体对化疗治疗早期反应的全基因表达分析
BMC Genomics. 2008 Feb 26;9:99. doi: 10.1186/1471-2164-9-99.

本文引用的文献

1
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach.卵巢癌的免疫治疗:迈向基于个体化免疫表型的方法。
Nat Rev Clin Oncol. 2024 Nov;21(11):801-817. doi: 10.1038/s41571-024-00937-4. Epub 2024 Sep 4.
2
Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence.Ki67在上皮性卵巢癌中的预后价值:新辅助化疗后Ki67联合CA125预测复发
Cancer Manag Res. 2024 Jul 9;16:761-769. doi: 10.2147/CMAR.S469132. eCollection 2024.
3
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology.
患者来源的肿瘤类器官:肿瘤学临床前研究和精准医学的新途径。
Exp Mol Med. 2024 Jul;56(7):1531-1551. doi: 10.1038/s12276-024-01272-5. Epub 2024 Jul 1.
4
A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine.关于用于癌症研究和个性化医疗的3D肿瘤类器官培养方法及应用的系统综述。
Cell Oncol (Dordr). 2025 Feb;48(1):1-26. doi: 10.1007/s13402-024-00960-8. Epub 2024 May 28.
5
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial.尼拉帕利、度伐利尤单抗和贝伐珠单抗联合治疗预处理的晚期铂耐药卵巢癌:来自 OPAL 二期试验 A 队列的结果。
JCO Precis Oncol. 2024 May;8:e2300693. doi: 10.1200/PO.23.00693.
6
In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models.卵巢癌的体外模型:连接病理生理学和机制模型之间的差距。
Biomolecules. 2023 Jan 4;13(1):103. doi: 10.3390/biom13010103.
7
Ovarian cancer mutational processes drive site-specific immune evasion.卵巢癌突变过程驱动特定部位的免疫逃逸。
Nature. 2022 Dec;612(7941):778-786. doi: 10.1038/s41586-022-05496-1. Epub 2022 Dec 14.
8
Mini- and macro-scale direct perfusion bioreactors with optimized flow for engineering 3D tissues.具有优化流场的微型和宏观尺度直接灌注生物反应器,用于构建三维组织。
Biotechnol J. 2023 Feb;18(2):e2200405. doi: 10.1002/biot.202200405. Epub 2022 Dec 5.
9
A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery.一种多组学方法揭示了CD45表达在预后和新靶点发现中的作用。
Front Genet. 2022 Aug 17;13:928328. doi: 10.3389/fgene.2022.928328. eCollection 2022.
10
Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery.胶质母细胞瘤外植体的免疫疗法可诱导肿瘤中心而非外周产生γ干扰素反应及空间免疫细胞重排。
Sci Adv. 2022 Jul;8(26):eabn9440. doi: 10.1126/sciadv.abn9440. Epub 2022 Jul 1.